|
"kim tae min"的相關文件
顯示項目 1-2 / 2 (共1頁) 1 每頁顯示[10|25|50]項目
臺大學術典藏 |
2020-07-07T08:21:02Z |
Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study
|
Kim, Tae Min; Goldman, Jonathan W.; Natale, Ronald B.; Brown, Andrew P.; Collins, Barbara; Chmielecki, Juliann; Vishwanathan, Karthick; Mendoza-Naranjo, Ariadna; Ahn, Myung-Ju; Stathes Paganis; Lee, Dae H.; Ahn, Jin-Seok; Yang, James C.H.; Kim, Sang-We; Kim, Dong-Wan; Lee, Jong-Seok; Cho, Byoung Chul; Yang, James C.H.;Kim, Sang-We;Kim, Dong-Wan;Lee, Jong-Seok;Cho, Byoung Chul;Ahn, Jin-Seok;Lee, Dae H.;Kim, Tae Min;Goldman, Jonathan W.;Natale, Ronald B.;Brown, Andrew P.;Collins, Barbara;Chmielecki, Juliann;Vishwanathan, Karthick;Mendoza-Naranjo, Ariadna;Ahn, Myung-Ju |
國立臺灣大學 |
2015 |
Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 dose
|
Venkatakrishnan, Karthik; Kim, Tae Min; Lin, Chia-Chi; Thye, Lim Soon; Chng, Wee Joo; Ma, Brigette; Chen, Ming Huang; Zhou, Xiaofei; Liu, Hua; Kelly, Virginia; Kim, Won Seog; 林家齊 |
顯示項目 1-2 / 2 (共1頁) 1 每頁顯示[10|25|50]項目
|